ID   ENOG_HUMAN              Reviewed;         434 AA.
AC   P09104; B7Z2X9; Q96J33;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-APR-2021, entry version 236.
DE   RecName: Full=Gamma-enolase;
DE            EC=4.2.1.11;
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 2;
DE   AltName: Full=Neural enolase;
DE   AltName: Full=Neuron-specific enolase;
DE            Short=NSE;
GN   Name=ENO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Retina;
RX   PubMed=3208766; DOI=10.1111/j.1432-1033.1988.tb14465.x;
RA   McAleese S.M., Dunbar B., Fothergill J., Hinks L., Day I.N.M.;
RT   "Complete amino acid sequence of the neurone-specific gamma isozyme of
RT   enolase (NSE) from human brain and comparison with the non-neuronal alpha
RT   form (NNE).";
RL   Eur. J. Biochem. 178:413-417(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=3385803; DOI=10.1002/jnr.490190409;
RA   van Obberghen E., Kamholz J., Bishop J.G. III, Zomzely-Neurath C.,
RA   Lazzarini R.A.;
RT   "Human gamma enolase: isolation of a cDNA clone and expression in normal
RT   and tumor tissues of human origin.";
RL   J. Neurosci. Res. 19:450-456(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2792767; DOI=10.1016/0378-1119(89)90217-5;
RA   Oliva D., Barba G., Barbieri G., Giallongo A., Feo S.;
RT   "Cloning, expression and sequence homologies of cDNA for human gamma
RT   enolase.";
RL   Gene 79:355-360(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Hematopoietic;
RX   PubMed=2045099; DOI=10.1016/0888-7543(91)90496-2;
RA   Oliva D., Cali L., Feo S., Giallongo A.;
RT   "Complete structure of the human gene encoding neuron-specific enolase.";
RL   Genomics 10:157-165(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 16-28; 33-50; 90-103; 163-179; 184-193; 240-262;
RP   270-285; 336-372 AND 413-422, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-434 (ISOFORM 1/2).
RX   PubMed=3653393; DOI=10.1016/0014-5793(87)80207-7;
RA   Day I.N.M., Allsopp M.T.E.P., Moore D.C.M., Thompson R.J.;
RT   "Sequence conservation in the 3'-untranslated regions of neurone-specific
RT   enolase, lymphokine and protooncogene mRNAs.";
RL   FEBS Lett. 222:139-143(1987).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-26, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   HYDROXYBUTYRYLATION AT LYS-233.
RX   PubMed=29775581; DOI=10.1016/j.molcel.2018.04.011;
RA   Huang H., Tang S., Ji M., Tang Z., Shimada M., Liu X., Qi S.,
RA   Locasale J.W., Roeder R.G., Zhao Y., Li X.;
RT   "p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis.";
RL   Mol. Cell 70:663-678(2018).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS.
RX   PubMed=15289101; DOI=10.1016/j.jmb.2004.05.068;
RA   Chai G., Brewer J.M., Lovelace L.L., Aoki T., Minor W., Lebioda L.;
RT   "Expression, purification and the 1.8 angstroms resolution crystal
RT   structure of human neuron specific enolase.";
RL   J. Mol. Biol. 341:1015-1021(2004).
CC   -!- FUNCTION: Has neurotrophic and neuroprotective properties on a broad
CC       spectrum of central nervous system (CNS) neurons. Binds, in a calcium-
CC       dependent manner, to cultured neocortical neurons and promotes cell
CC       survival (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289,
CC         ChEBI:CHEBI:58702; EC=4.2.1.11;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits, alpha,
CC       beta and gamma, which can form homodimers or heterodimers which are
CC       cell-type and development-specific. {ECO:0000269|PubMed:15289101}.
CC   -!- INTERACTION:
CC       P09104; Q9BSI4: TINF2; NbExp=2; IntAct=EBI-713154, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Note=Can translocate to the plasma membrane in either
CC       the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09104-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09104-2; Sequence=VSP_055482;
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in embryo
CC       and in most adult tissues. The alpha/beta heterodimer and the beta/beta
CC       homodimer are found in striated muscle, and the alpha/gamma heterodimer
CC       and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition from the
CC       alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle
CC       cells, and to the alpha/gamma heterodimer in nerve cells.
CC   -!- INDUCTION: Levels of ENO2 increase dramatically in cardiovascular
CC       accidents, cerebral trauma, brain tumors and Creutzfeldt-Jakob disease.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52388.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13120; CAA31512.1; -; mRNA.
DR   EMBL; X14327; CAA32505.1; -; mRNA.
DR   EMBL; M36768; AAA52388.1; ALT_INIT; mRNA.
DR   EMBL; M22349; AAB59554.1; -; mRNA.
DR   EMBL; X51956; CAA36215.1; -; Genomic_DNA.
DR   EMBL; AK295220; BAH12015.1; -; mRNA.
DR   EMBL; BT007383; AAP36047.1; -; mRNA.
DR   EMBL; U47924; AAB51320.1; -; Genomic_DNA.
DR   EMBL; BC002745; AAH02745.1; -; mRNA.
DR   CCDS; CCDS8570.1; -. [P09104-1]
DR   PIR; JU0060; NOHUG.
DR   RefSeq; NP_001966.1; NM_001975.2. [P09104-1]
DR   PDB; 1TE6; X-ray; 1.80 A; A/B=2-434.
DR   PDB; 2AKM; X-ray; 1.92 A; A/B=2-434.
DR   PDB; 2AKZ; X-ray; 1.36 A; A/B=2-434.
DR   PDB; 3UCC; X-ray; 1.50 A; A/B=2-434.
DR   PDB; 3UCD; X-ray; 1.41 A; A/B=2-434.
DR   PDB; 3UJE; X-ray; 1.55 A; A/B=2-434.
DR   PDB; 3UJF; X-ray; 2.10 A; A/B=2-434.
DR   PDB; 3UJR; X-ray; 1.40 A; A/B=2-434.
DR   PDB; 3UJS; X-ray; 1.65 A; A/B=2-434.
DR   PDB; 4ZA0; X-ray; 2.31 A; A/B=1-434.
DR   PDB; 4ZCW; X-ray; 1.99 A; A/B=1-434.
DR   PDB; 5EU9; X-ray; 2.05 A; A/B/C/D/E/F/G/H=1-434.
DR   PDB; 5IDZ; X-ray; 2.63 A; A/B=1-434.
DR   PDB; 5TD9; X-ray; 2.32 A; A/B=1-434.
DR   PDB; 5TIJ; X-ray; 2.63 A; A/B=1-434.
DR   PDBsum; 1TE6; -.
DR   PDBsum; 2AKM; -.
DR   PDBsum; 2AKZ; -.
DR   PDBsum; 3UCC; -.
DR   PDBsum; 3UCD; -.
DR   PDBsum; 3UJE; -.
DR   PDBsum; 3UJF; -.
DR   PDBsum; 3UJR; -.
DR   PDBsum; 3UJS; -.
DR   PDBsum; 4ZA0; -.
DR   PDBsum; 4ZCW; -.
DR   PDBsum; 5EU9; -.
DR   PDBsum; 5IDZ; -.
DR   PDBsum; 5TD9; -.
DR   PDBsum; 5TIJ; -.
DR   SMR; P09104; -.
DR   BioGRID; 108340; 109.
DR   IntAct; P09104; 37.
DR   MINT; P09104; -.
DR   STRING; 9606.ENSP00000437402; -.
DR   BindingDB; P09104; -.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   iPTMnet; P09104; -.
DR   MetOSite; P09104; -.
DR   PhosphoSitePlus; P09104; -.
DR   SwissPalm; P09104; -.
DR   BioMuta; ENO2; -.
DR   DMDM; 20981682; -.
DR   OGP; P09104; -.
DR   UCD-2DPAGE; P09104; -.
DR   EPD; P09104; -.
DR   jPOST; P09104; -.
DR   MassIVE; P09104; -.
DR   PaxDb; P09104; -.
DR   PeptideAtlas; P09104; -.
DR   PRIDE; P09104; -.
DR   ProteomicsDB; 52198; -. [P09104-1]
DR   ProteomicsDB; 6473; -.
DR   Antibodypedia; 3514; 2044 antibodies.
DR   DNASU; 2026; -.
DR   Ensembl; ENST00000229277; ENSP00000229277; ENSG00000111674. [P09104-1]
DR   Ensembl; ENST00000535366; ENSP00000437402; ENSG00000111674. [P09104-1]
DR   Ensembl; ENST00000538763; ENSP00000441490; ENSG00000111674. [P09104-2]
DR   Ensembl; ENST00000541477; ENSP00000438873; ENSG00000111674. [P09104-1]
DR   GeneID; 2026; -.
DR   KEGG; hsa:2026; -.
DR   UCSC; uc058knm.1; human. [P09104-1]
DR   CTD; 2026; -.
DR   DisGeNET; 2026; -.
DR   GeneCards; ENO2; -.
DR   HGNC; HGNC:3353; ENO2.
DR   HPA; ENSG00000111674; Tissue enriched (brain).
DR   MIM; 131360; gene.
DR   neXtProt; NX_P09104; -.
DR   OpenTargets; ENSG00000111674; -.
DR   PharmGKB; PA27788; -.
DR   VEuPathDB; HostDB:ENSG00000111674.8; -.
DR   eggNOG; KOG2670; Eukaryota.
DR   GeneTree; ENSGT00950000182805; -.
DR   HOGENOM; CLU_031223_0_0_1; -.
DR   InParanoid; P09104; -.
DR   OMA; RYKGKAQ; -.
DR   PhylomeDB; P09104; -.
DR   TreeFam; TF300391; -.
DR   BioCyc; MetaCyc:HS10646-MONOMER; -.
DR   BRENDA; 4.2.1.11; 2681.
DR   PathwayCommons; P09104; -.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P09104; -.
DR   UniPathway; UPA00109; UER00187.
DR   BioGRID-ORCS; 2026; 9 hits in 993 CRISPR screens.
DR   ChiTaRS; ENO2; human.
DR   EvolutionaryTrace; P09104; -.
DR   GeneWiki; Enolase_2; -.
DR   GenomeRNAi; 2026; -.
DR   Pharos; P09104; Tbio.
DR   PRO; PR:P09104; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P09104; protein.
DR   Bgee; ENSG00000111674; Expressed in right hemisphere of cerebellum and 209 other tissues.
DR   ExpressionAtlas; P09104; baseline and differential.
DR   Genevisible; P09104; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:CAFA.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IBA:GO_Central.
DR   GO; GO:0001917; C:photoreceptor inner segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; ISS:CAFA.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0006096; P:glycolytic process; ISS:CAFA.
DR   GO; GO:0032889; P:regulation of vacuole fusion, non-autophagic; IBA:GO_Central.
DR   CDD; cd03313; enolase; 1.
DR   Gene3D; 3.20.20.120; -; 1.
DR   Gene3D; 3.30.390.10; -; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR036849; Enolase-like_C_sf.
DR   InterPro; IPR029017; Enolase-like_N.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   PANTHER; PTHR11902; PTHR11902; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SFLD; SFLDF00002; enolase; 1.
DR   SMART; SM01192; Enolase_C; 1.
DR   SMART; SM01193; Enolase_N; 1.
DR   SUPFAM; SSF51604; SSF51604; 1.
DR   SUPFAM; SSF54826; SSF54826; 1.
DR   TIGRFAMs; TIGR01060; eno; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane; Cytoplasm;
KW   Direct protein sequencing; Glycolysis; Hydroxylation; Isopeptide bond;
KW   Lyase; Magnesium; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   CHAIN           2..434
FT                   /note="Gamma-enolase"
FT                   /id="PRO_0000134112"
FT   REGION          370..373
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   ACT_SITE        210
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   METAL           40
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   METAL           245
FT                   /note="Magnesium"
FT   METAL           245
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   METAL           293
FT                   /note="Magnesium"
FT   METAL           293
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   METAL           318
FT                   /note="Magnesium"
FT   METAL           318
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   BINDING         158
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         167
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         293
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         318
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   BINDING         394
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P00924"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         26
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         44
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         60
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         60
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         64
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         89
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         197
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17183"
FT   MOD_RES         202
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         228
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         228
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         233
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:29775581"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         256
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         287
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   MOD_RES         335
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         343
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   MOD_RES         406
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17182"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06733"
FT   VAR_SEQ         61..104
FT                   /note="GVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKS -> A
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055482"
FT   VARIANT         264
FT                   /note="P -> A"
FT                   /id="VAR_002354"
FT   VARIANT         395
FT                   /note="T -> A"
FT                   /id="VAR_002355"
FT   CONFLICT        4
FT                   /note="E -> Q (in Ref. 1; CAA31512/CAA32505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        27..28
FT                   /note="AK -> GC (in Ref. 2; AAA52388)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="E -> N (in Ref. 2; AAA52388)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240
FT                   /note="I -> M (in Ref. 1; CAA31512/CAA32505)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..12
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          18..26
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          29..34
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          43..45
FT                   /evidence="ECO:0007744|PDB:5TD9"
FT   TURN            54..56
FT                   /evidence="ECO:0007744|PDB:5TD9"
FT   HELIX           57..59
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           63..71
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           73..80
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           87..98
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          100..102
FT                   /evidence="ECO:0007744|PDB:5TD9"
FT   TURN            104..106
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           108..126
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           130..138
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          147..154
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           156..158
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          159..162
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          167..171
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           178..200
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           202..205
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          211..213
FT                   /evidence="ECO:0007744|PDB:3UJF"
FT   HELIX           220..234
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   TURN            237..239
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          241..245
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           248..251
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          254..257
FT                   /evidence="ECO:0007744|PDB:2AKM"
FT   TURN            259..262
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           267..269
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           273..286
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          289..293
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           301..309
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          312..318
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   TURN            319..323
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           325..333
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          338..342
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           344..347
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           350..362
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          366..370
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           380..388
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   STRAND          391..394
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           401..417
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           418..420
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           425..427
FT                   /evidence="ECO:0007744|PDB:2AKZ"
FT   HELIX           431..433
FT                   /evidence="ECO:0007744|PDB:2AKZ"
SQ   SEQUENCE   434 AA;  47269 MW;  6163DE81F5C67744 CRC64;
     MSIEKIWARE ILDSRGNPTV EVDLYTAKGL FRAAVPSGAS TGIYEALELR DGDKQRYLGK
     GVLKAVDHIN STIAPALISS GLSVVEQEKL DNLMLELDGT ENKSKFGANA ILGVSLAVCK
     AGAAERELPL YRHIAQLAGN SDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAESFRD
     AMRLGAEVYH TLKGVIKDKY GKDATNVGDE GGFAPNILEN SEALELVKEA IDKAGYTEKI
     VIGMDVAASE FYRDGKYDLD FKSPTDPSRY ITGDQLGALY QDFVRDYPVV SIEDPFDQDD
     WAAWSKFTAN VGIQIVGDDL TVTNPKRIER AVEEKACNCL LLKVNQIGSV TEAIQACKLA
     QENGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEELGDE
     ARFAGHNFRN PSVL
//
